Radiation therapy concurrent with weekly cisplatin therapy for loco-regionally advanced nasopharyngeal carcinoma: outcomes of a clinical trial
Daiyuan Ma(North Sichuan Medical University), Yeqin Zhou(North Sichuan Medical University), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), Chunqiao Fu(North Sichuan Medical University), LI Xian-fu(North Sichuan Medical University), Mi Liu(Chinese Center For Disease Control and Prevention)
Cited by 1
Related Papers
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
|Radiotherapy and Oncology|2017|104
Research progress on the mechanism of radiation enteritis
|Frontiers in Oncology|2022|42
Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study
|Radiation Oncology|2014|41
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial
|International Journal of Radiation Oncology*Biology*Physics|2023|34